Investor Relations

News Releases

Date Title and Summary Additional Formats
Toggle Summary Anika Reports Fourth Quarter and Full Year 2016 Financial Results
Worldwide Orthobiologics Revenue Increases 13% Year-over-Year for Fourth Quarter of 2016 Product Revenue Grows 17% for Full Year of 2016 BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based
View HTML
Toggle Summary Anika to Issue Fourth-Quarter 2016 Financial Results and Business Highlights on Wednesday, February 15
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter 2016 financial results after the close of the market on Wednesday, February 15, 2017 and to hold a conference call the next day, Thursday, February 16, 2017
View HTML
Toggle Summary Anika Wins CE Mark Approval For ORTHOVISC®-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. , ( NASDAQ : ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid "HA" technology , today announced that it received CE Mark approval for ORTHOVISC-T (sodium
View HTML
Toggle Summary Anika to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 29, 2016
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that its Chief Financial Officer, Sylvia Cheung , will make a
View HTML
Toggle Summary Anika Reports Third Quarter 2016 Financial Results
Worldwide Orthobiologics Revenue Increases 10% Year-over-Year Diluted Earnings Per Share Increases to $0.59 BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary
View HTML
Toggle Summary Anika to Issue Third-Quarter 2016 Financial Results and Business Highlights on Wednesday, October 26
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK) today announced that the Company plans to issue its third-quarter 2016 financial results after the close of the market on Wednesday, October 26, 2016 and to hold a conference call the next day, Thursday, October 27, 2016 ,
View HTML
Toggle Summary Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society
-- Podium Sessions Showcase Studies Comparing HYALOFAST versus Collagen Scaffold and Microfracture Surgery for Cartilage Repair -- BEDFORD, Mass. & NAPLES, Italy --(BUSINESS WIRE)-- Anika Therapeutics, Inc. , ( NASDAQ : ANIK), a global, integrated orthopedics medicines company specializing in
View HTML
Toggle Summary Anika to Participate in Upcoming Investor Conferences
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that its Chief Financial Officer, Sylvia Cheung , will
View HTML
Toggle Summary Anika Reports Second Quarter 2016 Financial Results
Total Revenue Increases 16% Year-over-Year BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today reported financial results for
View HTML
Toggle Summary Anika to Issue Second-Quarter 2016 Financial Results and Business Highlights on Wednesday, July 27
BEDFORD, Mass. --(BUSINESS WIRE)-- Anika Therapeutics, Inc. ( NASDAQ : ANIK) today announced that the Company plans to issue its second-quarter 2016 financial results after the close of the market on Wednesday, July 27, 2016 and to hold a conference call the next day, Thursday, July 28, 2016 , at
View HTML